Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+2.7%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$44.8B
AUM Growth
+$1.68B
(+3.9%)
Cap. Flow
+$1.3B
Cap. Flow
% of AUM
2.91%
Top 10 Holdings %
Top 10 Hldgs %
18.43%
Holding
2,758
New
327
Increased
954
Reduced
1,123
Closed
344
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$351M |
| 2 |
Snowflake
SNOW
|
+$340M |
| 3 |
CME Group
CME
|
+$302M |
| 4 |
Uber
UBER
|
+$278M |
| 5 |
Costco
COST
|
+$275M |
Top Sells
| 1 |
Walmart
WMT
|
+$482M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 3 |
Qualcomm
QCOM
|
+$318M |
| 4 |
PepsiCo
PEP
|
+$295M |
| 5 |
Hewlett Packard
HPE
|
+$274M |
Sector Composition
| 1 | Technology | 25.12% |
| 2 | Healthcare | 14.71% |
| 3 | Financials | 14.34% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Lyell Immunopharma
LYEL
$251M
| $208K | ﹤0.01% |
7,165
+1,810
| +34% | +$52.5K |
|
|
ACRE
2202
Ares Commercial Real Estate
ACRE
$267M
| $207K | ﹤0.01% |
31,200
+8,700
| +39% | +$57.9K |
|
2203
ARS Pharmaceuticals
SPRY
$1.04B
| $207K | ﹤0.01% |
+24,300
| New | +$207K |
|
2204
Aehr Test Systems
AEHR
$790M
| $207K | ﹤0.01% |
+18,500
| New | +$207K |
|
2205
Bank First Corp
BFC
$1.26B
| $206K | ﹤0.01% |
2,500
-300
| -11% | -$24.8K |
|
2206
Asure Software
ASUR
$219M
| $206K | ﹤0.01% |
24,575
-91,825
| -79% | -$771K |
|
2207
Corvus Pharmaceuticals
CRVS
$442M
| $206K | ﹤0.01% |
113,400
-71,700
| -39% | -$130K |
|
2208
AMERISAFE
AMSF
$857M
| $206K | ﹤0.01% |
+4,700
| New | +$206K |
|
2209
Asbury Automotive
ABG
$4.86B
| $205K | ﹤0.01% |
+900
| New | +$205K |
|
2210
Markel Group
MKL
$24.3B
| $205K | ﹤0.01% |
+130
| New | +$205K |
|
2211
LCNB Corp
LCNB
$227M
| $204K | ﹤0.01% |
14,700
-1,300
| -8% | -$18.1K |
|
2212
Southern First Bancshares
SFST
$362M
| $202K | ﹤0.01% |
6,900
| – | – |
|
2213
Empire State Realty Trust
ESRT
$1.3B
| $202K | ﹤0.01% |
+21,500
| New | +$202K |
|
2214
REV Group
REVG
$3.06B
| $202K | ﹤0.01% |
8,100
-197,400
| -96% | -$4.91M |
|
2215
Cognyte Software
CGNT
$603M
| $201K | ﹤0.01% |
26,300
+2,000
| +8% | +$15.3K |
|
2216
Privia Health
PRVA
$2.78B
| $200K | ﹤0.01% |
+11,500
| New | +$200K |
|
2217
Star Group
SGU
$389M
| $199K | ﹤0.01% |
+18,700
| New | +$199K |
|
2218
Immersion
IMMR
$222M
| $198K | ﹤0.01% |
21,000
-121,600
| -85% | -$1.14M |
|
2219
Columbia Financial
CLBK
$1.6B
| $198K | ﹤0.01% |
+13,200
| New | +$198K |
|
2220
NerdWallet
NRDS
$788M
| $197K | ﹤0.01% |
+13,500
| New | +$197K |
|
2221
Lincoln Educational Services
LINC
$601M
| $197K | ﹤0.01% |
16,600
-35,100
| -68% | -$416K |
|
2222
Stoneridge
SRI
$229M
| $195K | ﹤0.01% |
12,200
-28,500
| -70% | -$455K |
|
2223
Prelude Therapeutics
PRLD
$67.4M
| $194K | ﹤0.01% |
50,900
-19,300
| -27% | -$73.5K |
|
2224
FerroAtlántica
GSM
$780M
| $193K | ﹤0.01% |
36,100
-33,000
| -48% | -$177K |
|
2225
CytomX Therapeutics
CTMX
$341M
| $193K | ﹤0.01% |
158,400
+11,600
| +8% | +$14.2K |
|